41270-65-9 Usage
Description
2-Chloro-3-phenylpyrazine, a pyrazine derivative with the molecular formula C9H7ClN2, is a chemical compound characterized by the presence of a chloro group and a phenyl group attached to the pyrazine ring. Its molecular structure and reactivity contribute to its diverse applications in various industries, including pharmaceuticals, agrochemicals, and the flavor and fragrance industry.
Uses
Used in Pharmaceutical and Agrochemical Industries:
2-Chloro-3-phenylpyrazine serves as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique molecular structure and reactivity make it a valuable component in the production of organic compounds with therapeutic or pesticidal properties.
Used in Flavor and Fragrance Industry:
Leveraging its aromatic properties, 2-Chloro-3-phenylpyrazine is employed in the flavor and fragrance industry to create unique scents and flavors for various consumer products.
Used in Insecticide Development:
2-Chloro-3-phenylpyrazine has been studied for its potential as an insecticide, with research exploring its ability to effectively control and manage insect populations.
Used in Anticancer Research:
As a potential anticancer agent, 2-Chloro-3-phenylpyrazine is under investigation for its biological activities that may contribute to the development of novel cancer treatments. Its specific mechanisms of action and potential synergistic effects with existing therapies are areas of ongoing research.
Check Digit Verification of cas no
The CAS Registry Mumber 41270-65-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,2,7 and 0 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 41270-65:
(7*4)+(6*1)+(5*2)+(4*7)+(3*0)+(2*6)+(1*5)=89
89 % 10 = 9
So 41270-65-9 is a valid CAS Registry Number.
41270-65-9Relevant articles and documents
SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF
-
Page/Page column 77; 79-80, (2021/06/26)
The present invention relates to the field of medicine. More specifically, the present invention relates to compounds that are sigma-1 receptor agonists and their use for the treatment of central nervous system disorders, including cognitive or neurodegen
N - acyl - [...] P 2X7 adjustment
-
Paragraph 0592-0594, (2017/10/28)
The present invention is directed to compounds of Formula (I), which includes enantiomer and diasteromers thereof: These compounds are suitable for use in the treatment of diseases associated with P2X7 receptor activity such as diseases of the autoimmune
Studies on pyrazines. 35 [1]. An improved synthesis of bromopyrazines from hydroxypyrazines
Sato, Nobuhiro,Narita, Nobuhiko
, p. 783 - 786 (2007/10/03)
The synthesis of bromopyrazines from hydroxypyrazines was successfully effected by the procedure via trimethylsilyloxypyrazines, the sequence of which proceeds under mild conditions and does not require the isolation of intermediate.
